What contractual protections should be in a pilot agreement?

How to answer this, stage by stage

A contract question sounds like a legal question. It is really a risk question, and the interviewer wants to see you find the people the contract forgets, not recite clause names. Seven moves get you there.

Let's learn

Here is what happens when one contract works fine for years, then for one industry, it does not.

Coventree Systems builds Fairclaim. Type in a drug's approved facts and who the ad is for, and Fairclaim writes a full first draft, a headline, sales aid bullets, a patient brochure, whatever the ad agency asked for, in minutes instead of days.

Every pilot Coventree ran, for years, used the same sixty day contract. Either side could walk away with two weeks' notice, no extra terms. It ran fine with grocery chains and skincare brands. A first draft that used to take a copywriter three days came back in under an hour. If a headline came out wrong, someone rewrote it. An hour lost, nothing more.

Then Rundlett Health Partners, an agency that only works with pharma brands, asked to pilot Fairclaim on a launch campaign for Corvassa Pharmaceuticals' new heart drug, Nelvora. Coventree sent the same sixty day contract, names swapped, nothing else changed. The draft time dropped the same way, three days to under an hour, this time on real client work headed for a regulator's desk.

Here is the turn. The risk was never that Fairclaim would get something wrong. Everyone in the room already knew a model gets things wrong sometimes. The real problem is that the contract never said how wrong was too wrong, or who owned a mistake once someone found it. Nobody had written down what happens on the day the real number turns out worse than the demo's number.

On Coventree's own demo, a curated set of fifty marketing drafts, about two in every hundred claims got flagged by a reviewer as overstated or unsupported. Once Fairclaim started writing real Nelvora drafts at real pilot volume, that number climbed. By the fourth week, it had reached six in every hundred.

At its worst, this costs more than one bad headline. Rundlett's own reviewer catches an overstated claim about Nelvora before it goes anywhere, purely by luck. Nobody outside the building ever sees it. But now Rundlett has to decide alone: keep paying for a tool that might do this again, with no number telling them when to stop, or cancel the whole pilot and lose the thing that was cutting three days down to one hour. And Coventree loses something worth more than the pilot itself, the one flagged draft that shows exactly how Fairclaim gets a claim wrong.

The choice I would take back is not building Fairclaim. It is using one pilot contract for every industry, because writing a separate version for the handful of pharma pilots a year felt like slow legal work for a small slice of the business. Small, and it made sense at the time.

What I would leave alone: the grocery chain and skincare pilots never needed any of this. A wrong headline there costs a rewrite, not a regulator's attention, so pushing pharma grade contract weight onto every pilot would slow down the ninety percent of the business that was never the problem.

The lesson: a pilot contract's job is not to promise the demo was right. It is to say, in writing, what happens on the day it was not, and who gets to keep what was learned from that day.

Corin wrote the same sixty day contract every time. Rundlett only found out what it did not cover after they had already signed it.

Now here is the same thing as a story

Use this version when you have room to breathe. The short version is above.

Corin Marchak runs pilot partnerships at Coventree Systems. Three years in, she can tell which client will sign after a pilot before the demo even ends, just from how they react to the first draft coming back in under a minute.

For most of those three years, sending a pilot contract was the easy part of her week. She would open the template outside counsel had built once, swap in the new client's name, and send it that same afternoon. It worked so well that she stopped reading it line by line. It had closed a grocery chain, three skincare brands, a meal kit company, all without a single argument over a single clause.

Then Rundlett Health Partners called about Corvassa Pharmaceuticals' new heart drug, Nelvora. Corin sent the same sixty day contract, same afternoon as always, names swapped, nothing else read twice.

The pilot ran the way pilots always ran for her. Draft time fell from three days to under an hour, and Rundlett's writers loved it. For three weeks, nothing about this pilot looked any different from the last ten.

Then, on a Thursday, Rundlett's own compliance reviewer, checking a Nelvora sales aid before it went to Corvassa's review board, flagged one line. Fairclaim had written that Nelvora cut serious cardiac events by a number the actual trial data did not support at that size. The reviewer caught it. Nobody outside Rundlett ever saw it.

Corin heard about it secondhand, in a short, careful email from Rundlett's head of compliance, asking one question: if this happens again next month, what does our contract actually say?

Corin pulled up the contract to answer that question and found she could not. There was no line anywhere that said how much of this was too much. There was no line that said what happened to the flagged draft itself, the one thing that could have taught Fairclaim not to do this again. It just sat in an email thread, then disappeared.

This was never really about the six in a hundred. Corin never had a number in her head for what was safe to send. She had a feeling, and the feeling only had two settings: send the standard contract, or stop and rebuild the entire risk section from scratch. There was no middle setting where she just added one line and moved on.

The old decision, told as a memory of a real meeting: when outside counsel first built the standard pilot template, the room agreed that one contract, reused everywhere, beat writing a new one for every client. Pharma pilots were maybe two deals a year out of thirty. Spending real legal hours on two deals, to protect against a failure nobody had seen yet, looked like the wrong two hours to spend. Nobody in that room was wrong about what the numbers showed them then.

Every step in this line has someone checking it, until the very last one. Nobody wrote a step for the person actually reading the ad.

Here is the replay. On the next pharma pilot, a different drug company through a different agency, Corin sends a contract with two new lines in it. One says the agency can leave with no penalty the moment the flagged claim rate crosses four in a hundred, checked every two weeks against real drafts. The other says Coventree can collect every flagged draft, patient details stripped out, to build the exact set that catches this kind of mistake next time.

Three weeks in, the same kind of overstated claim shows up in a different draft. This time it becomes labeled example one in Coventree's new pharma claims set within a day. Two weeks after that, the flagged rate crosses four in a hundred. The agency invokes the clause, cleanly, no argument, no lost relationship. Six months later, when the same drug company launches its next drug, they call Coventree first.

What I would tell my past self, back in that meeting about the standard template: a contract that only gets easier to sign is not the same thing as a contract that is actually safe to sign.

GUARD, run straight at the contract itself

This is a risk question wearing a legal question's clothes. Something can go wrong for a person who never gets a vote in the contract that lets it happen. GUARD fits, and the two clauses above are what G through D actually build.

Two things worth saying out loud here, since this is exactly where a real AI product question earns its name. First, the plain fix most people reach for is a clause that lets either side walk away, for any reason, any time. That option was considered and set aside, because it hands Rundlett an exit with no number attached to it, and it gives Coventree nothing back, no claim on the draft that actually caused the walk away. It answers the wrong version of the question. Second, the real bar in the exit clause is not zero flagged claims, ever. Fairclaim already routes any draft that states a specific efficacy or safety number through a required check by a person before it can leave draft status. That is the guardrail against the real failure here, a model writing an unsupported claim in a tone every bit as confident as a true one. Widen that check to catch more borderline claims and the pilot slows down, drafts stack up waiting on a reviewer, and the whole reason anyone signed up, three days down to one hour, starts to disappear. The exit line has to sit at a number that is real and measured against actual drafts, not a promise that nothing will ever go wrong.

And if you want to be sure it really works, try it somewhere else

Same five letters, a different pilot, a long way from pharma, so the method proves itself instead of repeating a story you rehearsed once.

Verrance Analytics sells Ledgerpoint, a tool that scores small business loan applications for community banks, to Osgrove Community Bank, so a loan officer can clear the easy approvals fast and spend real time on the ones that need a human look.

G. Three groups again. Verrance, who built Ledgerpoint. Osgrove, who runs it on real applications. And the small business owners applying for a loan, who never sign anything with either company.
U. Leave the pilot contract silent and the bank absorbs every fair lending question a wrong decline creates, while a declined applicant, especially one who has never banked there before, absorbs a closed door with no idea a model was involved at all.
A. An existing customer at least has a loan officer who might double check a borderline decline out of habit. A stranger applying cold has nobody in the building who would ever think to look twice.
R. The clause: Osgrove has to give a plain reason behind any Ledgerpoint influenced decline, on request, and any decline that sits close to Ledgerpoint's own cut off line gets a human loan officer's look before it goes out, not after a complaint comes in.
D. Track, every week, how often a loan officer overturns a near cut off decline once they actually look, split by whether the applicant already banks there. If that overturn rate climbs for new to the bank applicants and stays flat for existing ones, that is the bar working unevenly before anyone outside the bank ever notices.

Swap the trigger and it still runs.
Speed: an interviewer cuts you off after ninety seconds. Skip straight to the two clauses and the number they are tied to.
Cost: legal says a full pharma specific contract addendum takes six weeks to draft. Do not leave the pilot running with no protection in the meantime. Ship the exit line alone inside the existing template now, tracked by hand if the automated eval set is not ready, and add the data clause once the addendum lands.
The model got better, for real: say Fairclaim's flagged claim rate provably drops across every account Coventree has. That is not proof this particular account is safe, so the clause and the tracking stay in the contract. A lower number becomes evidence the system is working, not a reason to take the protection back out.

Where people run it wrong.
They write a plain either side can walk away clause and call it protection, but it gives nobody a number, so nobody can tell the difference between the model actually failing and someone just changing their mind.
They promise a hard zero, no regulatory errors ever, which is not honest about a model that answers in probabilities, and forces one side to either lie or refuse to sign.
They let a flagged failure get talked about over email instead of written into a data clause, so the one case the model most needed to learn from quietly disappears the moment the pilot ends.

How to use it live. Repeat the two, sometimes three, groups back before you name a single clause. It shows the interviewer you looked past "the customer" for who else is standing in this deal, and it buys you a few seconds to pick the sharpest example.

Flashcards (click a card to flip it)

Check yourself Score: 0 / 0